衰弱老年人血压与心血管结局及全因死亡率的关联
基于英国初级保健电子健康记录(n=415,980)的前瞻性观察分析显示,在≥75岁人群中,收缩压<130 mmHg和舒张压<80 mmHg与超额死亡风险相关;收缩压>150 mmHg与心血管事件风险增加相关;在>85岁或75-84岁中度/重度衰弱者中,高血压与死亡率增加无关。
要点
- ≥75岁初级保健人群中,血压<130/80与超额死亡风险相关。
- 收缩压>150 mmHg与心血管结局风险增加相关。
- >85岁或75-84岁中度/重度衰弱者中,高血压与死亡率增加无关。
核心结论
- 在≥75岁代表性初级保健患者中,血压<130/80与超额死亡率相关。
- 高血压在>85岁或75-84岁中度/重度衰弱者中与死亡率增加无关。
- 对衰弱老年人积极降压的优先地位需进一步评估。
研究设计与样本
- 前瞻性观察分析,使用电子健康记录(临床实践研究数据链,n=415,980)。
- 随访≤10年,按基线电子衰弱指数分层:健康(非衰弱)、轻度、中度、重度衰弱。
- 采用竞争风险模型和Cox比例风险模型分别检验血压与心血管事件和死亡率的关联。
主要发现
- 心血管结局风险在收缩压>150 mmHg时增加。
- 死亡率关联在非衰弱<85岁与衰弱75-84岁及所有>85岁人群间不同。
- 收缩压高于130-139 mmHg参照值时与较低死亡风险相关,尤其在中度至重度衰弱或>85岁者(如75-84岁:150-159 mmHg vs 130-139:非衰弱HR=0.94,0.92-0.97;中度/重度衰弱HR=0.84,0.77-0.92)。
- 收缩压<130 mmHg和舒张压<80 mmHg一致与超额死亡率相关,独立于临终前血压轨迹。
关键数值与推荐
- 收缩压>150 mmHg与心血管结局风险增加相关。
- 收缩压<130 mmHg和舒张压<80 mmHg与超额死亡率相关。
- 75-84岁中度/重度衰弱者收缩压150-159 mmHg vs 130-139 mmHg的死亡率HR=0.84(0.77-0.92)。
- 75-84岁非衰弱者收缩压150-159 mmHg vs 130-139 mmHg的死亡率HR=0.94(0.92-0.97)。
临床怎么用
- 在≥75岁衰弱老年人中,降压目标需个体化,避免收缩压<130 mmHg和舒张压<80 mmHg。
- 对>85岁或75-84岁中度/重度衰弱者,不宜仅因高血压而强化降压。
- 需结合衰弱程度、共病和血压轨迹综合评估血压管理策略。
局限性
- 为观察性分析,不能推断因果关系。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Blood pressure (BP) management in frail older people is challenging. An randomised controlled trial of largely non-frail older people found cardiovascular and mortality benefit with systolic (S) BP target <120 mmHg. However, all-cause mortality by attained BP in routine care in frail adults aged above 75 is unclear. OBJECTIVES: To estimate observational associations between baseline BP and mortality/cardiovascular outcomes in a primary-care population aged above 75, stratified by frailty. METHODS: Prospective observational analysis using electronic health records (clinical practice research datalink, n = 415,980). We tested BP associations with cardiovascular events and mortality using competing and Cox proportional-hazards models respectively (follow-up ≤10 years), stratified by baseline electronic frailty index (eFI: fit (non-frail), mild, moderate, severe frailty), with sensitivity analyses on co-morbidity, cardiovascular risk and BP trajectory. RESULTS: Risks of cardiovascular outcomes increased with SBPs >150 mmHg. Associations with mortality varied between non-frail <85 and frail 75-84-year-olds and all above 85 years. SBPs above the 130-139-mmHg reference were associated with lower mortality risk, particularly in moderate to severe frailty or above 85 years (e.g. 75-84 years: 150-159 mmHg Hazard Ratio (HR) mortality compared to 130-139: non-frail HR = 0.94, 0.92-0.97; moderate/severe frailty HR = 0.84, 0.77-0.92). SBP <130 mmHg and Diastolic(D)BP <80 mmHg were consistently associated with excess mortality, independent of BP trajectory toward the end of life. CONCLUSIONS: In representative primary-care patients aged ≥75, BP <130/80 was associated with excess mortality. Hypertension was not associated with increased mortality at ages above 85 or at ages 75-84 with moderate/severe frailty, perhaps due to complexities of co-existing morbidities. The priority given to aggressive BP reduction in frail older people requires further evaluation.
引用
- Masoli JAH, Delgado J, Pilling L, et al. Blood pressure in frail older adults: associations with cardiovascular outcomes and all-cause mortality. Age Ageing. 2020. PMID: 32133525. doi:10.1093/ageing/afaa028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。